28 Feb 2024
Stocks mentioned: EPY |
Recommendation: Add
EPY reported Underlying NPAT of A$2.2m and pro-forma NPAT of A$2.9m. FY24 guidance is >A$4.8m...…
Read more
28 Feb 2024
Stocks mentioned: MAP |
Recommendation: Speculative Buy
MAP released its 1H results which are tracking in-line with our expectations. The imminent...…
Read more
28 Feb 2024
Stocks mentioned: MX1 |
Recommendation: Speculative Buy
Apart from the R&D incentive not being recognised as a receivable and the timing of project...…
Read more
28 Feb 2024
Stocks mentioned: EBR |
Recommendation: Speculative Buy
CY22 results were broadly in line, with opex up modestly and higher interest expense. The final...…
Read more
28 Feb 2024
Stocks mentioned: SLH |
Recommendation: Add
SLH delivered what is in our view a resilient 1H24 result in light of ongoing softness in trading...…
Read more
28 Feb 2024
Stocks mentioned: NHF |
Recommendation: Hold
NHF's 1H24 underlying operating profit (A$144m) was +13% above consensus, but was a low quality...…
Read more
27 Feb 2024
Stocks mentioned: COE |
Recommendation: Add
The real highlight in the 1H24 result was the progress reported at Orbost. With COE flagging...…
Read more
27 Feb 2024
Stocks mentioned: DGL |
Recommendation: Add
DGL delivered a weak 1H24, with NPAT declining 41% on the pcp, well below both our expectations...…
Read more
27 Feb 2024
Stocks mentioned: REH |
Recommendation: Reduce
REH's 1H24 result was above expectations with earnings growth delivered in both ANZ and the US...…
Read more
27 Feb 2024
Stocks mentioned: COL |
Recommendation: Add
COL's 1H24 results was above expectations driven mainly by the core Supermarkets segment. Key...…
Read more
-
Print this page
-
Copy Link